Validated on FFPE samples, the 60-gene SureSeq Solid Tumour Panel allows identification of novel and known variants in a range of tumours.
The complete array solution for clinical genetics research, including accurate and sensitive products and fully accredited service options.
High-quality FISH probes for the detection of gene rearrangements related to inherited genetic disease and cancer.
1 April 2015
OGT signs license with Wellcome Trust Sanger Institute
11 March 2015
Oxford Gene Technology awarded £1.2m Genomics England contract